2211 — Universal Health International Holding Income Statement
0.000.00%
Last trade - 00:00
- HK$30.04m
- HK$35.00m
- CNY1.30bn
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,424 | 1,510 | 1,185 | 1,274 | 1,297 |
Cost of Revenue | |||||
Gross Profit | 327 | 189 | 157 | 204 | 214 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,706 | 2,021 | 1,849 | 1,462 | 1,395 |
Operating Profit | -282 | -510 | -663 | -189 | -98.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -264 | -492 | -671 | -188 | -112 |
Provision for Income Taxes | |||||
Net Income After Taxes | -267 | -493 | -676 | -188 | -106 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -266 | -491 | -675 | -188 | -105 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -266 | -491 | -675 | -188 | -105 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.896 | -1.26 | -1.38 | -0.382 | -0.167 |